OBJECTIVES: Mucosal immunity plays a pivotal role for body defense against infection and allergy. The aim of this study was to clarify the effects of 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD) on mucosal immunity in the gut. METHODS: Fecal IgA level and oral tolerance induction were examined in TCDD-treated mice. Flow cytometric and histological analyses were also performed. RESULTS: Single oral administration of low dose 2,3,7,8-TCDD resulted in a marked decrease in IgA secretion in the gut without any effects on the cellular components of gut-associated lymphoid tissues (GALT) including Peyer's patches (PPs) and mesenteric lymph nodes (LNs). Decressed IgA secretion by TCDD was not observed in aryl hydrocarbon receptor (AhR)-deficient mice. Flow cytometric analysis revealed that IgA B cells in PPs and the mesenteric LNs remained unchanged in the TCDD-treated mice. An immunofluorescence study also demonstrated that a significant number of cytoplasmic IgA cells were present in the lamina propria of the gut in the TCDD-treated mice. Furthermore, oral tolerance induction by ovalbumin (OVA) was impaired in the TCDD-treated mice and OVA-specific T cell proliferation occurred in the peripheral lymphoid tissues including the spleen and LNs. CONCLUSIONS: These results suggest that a relatively low dose of TCDD impairs mucosal immunity in the gut and induces systemic sensitization by oral antigens.
OBJECTIVES: Mucosal immunity plays a pivotal role for body defense against infection and allergy. The aim of this study was to clarify the effects of 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD) on mucosal immunity in the gut. METHODS: Fecal IgA level and oral tolerance induction were examined in TCDD-treated mice. Flow cytometric and histological analyses were also performed. RESULTS: Single oral administration of low dose 2,3,7,8-TCDD resulted in a marked decrease in IgA secretion in the gut without any effects on the cellular components of gut-associated lymphoid tissues (GALT) including Peyer's patches (PPs) and mesenteric lymph nodes (LNs). Decressed IgA secretion by TCDD was not observed in aryl hydrocarbon receptor (AhR)-deficient mice. Flow cytometric analysis revealed that IgA B cells in PPs and the mesenteric LNs remained unchanged in the TCDD-treated mice. An immunofluorescence study also demonstrated that a significant number of cytoplasmic IgA cells were present in the lamina propria of the gut in the TCDD-treated mice. Furthermore, oral tolerance induction by ovalbumin (OVA) was impaired in the TCDD-treated mice and OVA-specific T cell proliferation occurred in the peripheral lymphoid tissues including the spleen and LNs. CONCLUSIONS: These results suggest that a relatively low dose of TCDD impairs mucosal immunity in the gut and induces systemic sensitization by oral antigens.
Authors: T W Spahn; A Fontana; A M Faria; A J Slavin; H P Eugster; X Zhang; P A Koni; N H Ruddle; R A Flavell; P D Rennert; H L Weiner Journal: Eur J Immunol Date: 2001-04 Impact factor: 5.532
Authors: Tao Wang; Katherine L Wyrick; Melanie R Pecka; Tamara B Wills; Beth A Vorderstrasse Journal: Int Immunopharmacol Date: 2012-05-23 Impact factor: 4.932
Authors: Clarisse S Muenyi; Sandra Leon Carrion; Lynn A Jones; Lawrence H Kennedy; Andrzej T Slominski; Carrie H Sutter; Thomas R Sutter Journal: Environ Health Perspect Date: 2014-06-06 Impact factor: 9.031
Authors: Shilpa Mokshagundam; Tianbing Ding; Jelonia T Rumph; Madison Dallas; Victoria R Stephens; Kevin G Osteen; Kaylon L Bruner-Tran Journal: Birth Defects Res Date: 2020-06-09 Impact factor: 2.661